LABORATORY CRP AMER HLDGS(NEW)
Reported by Thrivent Financial for Lutherans
Reported 895,433 shares, up 873,443 (3972.0%) from the prior quarter.
Reported value 3520.0%; share count 3972.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 6583000 |
| 2022-03-31 | 5797000 |
| 2022-06-30 | 209854000 |
| 2022-09-30 | 168525000 |
| 2022-12-31 | 145737000 |
| 2023-03-31 | 137335000 |
| 2023-06-30 | 172887000 |
| 2023-09-30 | 156487000 |
| 2023-12-31 | 177096000 |
| 2024-03-31 | 186350000 |
| 2024-06-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2024 | Reduced | 0 | -853,015 (-100.0%) | 0 | $0 | 2024-08-13 | |
| Q1 2024 | Added | 853,015 | +73,853 (9.5%) | 0.37% | $186,350,000 | 2024-05-14 | |
| Q4 2023 | Added | 779,162 | +821 (0.1%) | 0.39% | $177,096,000 | 2024-02-14 | |
| Q3 2023 | Added | 778,341 | +61,943 (8.6%) | 0.37% | $156,487,000 | 2023-11-14 | |
| Q2 2023 | Added | 716,398 | +117,776 (19.7%) | 0.39% | $172,887,000 | 2023-08-14 | |
| Q1 2023 | Reduced | 598,622 | -20,269 (-3.3%) | 0.33% | $137,335,000 | 2023-05-17 | |
| Q4 2022 | Reduced | 618,891 | -203,942 (-24.8%) | 0.38% | $145,737,000 | 2023-02-08 | |
| Q3 2022 | Reduced | 822,833 | -72,600 (-8.1%) | 0.46% | $168,525,000 | 2022-11-14 | |
| Q2 2022 | Added | 895,433 | +873,443 (3972.0%) | 0.56% | $209,854,000 | 2022-08-16 | |
| Q1 2022 | Added | 21,990 | +1,041 (5.0%) | 0.01% | $5,797,000 | 2022-05-13 | |
| Q4 2021 | Reduced | 20,949 | -668 (-3.1%) | 0.01% | $6,583,000 | 2022-02-16 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
1046 managers reported LABORATORY CRP AMER HLDGS(NEW) for Q2 2022.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| BlackRock Inc | Added | 11,184,279 | +1,607,500 | 0.08% | $2,621,148,000 | 37 qtrs |
| VANGUARD GROUP INC | Reduced | 10,822,930 | -36,198 | 0.07% | $2,536,462,000 | 37 qtrs |
| STATE STREET CORPORATION | Reduced | 4,240,566 | -56,540 | 0.06% | $993,819,000 | 37 qtrs |
| WELLINGTON MANAGEMENT GROUP LLP | Added | 2,861,147 | +128,520 | 0.14% | $670,539,000 | 37 qtrs |
| JPMorgan Chase & Co | Added | 1,904,199 | +633,452 | 0.06% | $446,269,000 | 37 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 1,886,677 | +22,461 | 0.06% | $441,693,000 | 37 qtrs |
| Bank of America Corporation | Added | 1,873,309 | +94,984 | 0.05% | $439,029,000 | 37 qtrs |
| DIMENSIONAL FUND ADVISORS LP | Added | 1,566,758 | +6,839 | 0.13% | $367,224,000 | 37 qtrs |
| FMR LLC | Added | 1,365,964 | +47,502 | 0.03% | $320,127,321 | 37 qtrs |
| UBS ASSET MANAGEMENT AMERICAS INC | Added | 1,205,517 | +124,119 | 0.15% | $282,524,967 | 37 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2022
- Filed
- August 16, 2022
- Filing type
- 13F-HR
- Position type
- COM NEW
Voting authority reported
- Sole
- 893,149
- Shared
- 0
- None
- 2,284
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.